Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

PGDx inks genome mapping license deal with Johns Hopkins
April 2013
SHARING OPTIONS:

BALTIMORE—Personal Genome Diagnostics Inc. (PGDx) has licensed the exclusive rights to Digital Karyotyping (DK), a genome-mapping technology developed by PGDx's founders at Johns Hopkins University. The rights include proprietary methods based on next-generation sequencing, patented approaches to genetic analysis and proprietary data algorithms. The DK technology facilitates quantitative analysis of DNA copy number at high resolution and sensitivity. Per the terms of the agreement, PGDx also has the right to sublicense the DK technology to third parties. PGDx has also announced plans to expand into new facilities.  
 
Antony Newton, PGDx's new chief commercial officer, said the company is "fortunate to be able to bring the latest advances in cancer genomics such as Digital Karyotyping to cancer researchers and clinicians around the globe."  
 

Back



PAGE UTILITIES


CONTACT US
DDNEWS
478 Bay Street, Suite A213
Midland, Ontario, Canada L4R 1K9
Ph: 888-781-0328 |  Fax: 705-528-0270
 
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.